Genentech drug Ocrevus (ocrelizumab) was approved
On Mar. 28, 2017, Genentech drug Ocrevus (ocrelizumab) was approved by the U.S. Food and Drug Administration (FDA)…
University of British Columbia researchers discovered a genetic link to multiple sclerosis
On Jun. 1, 2016, scientists at the University of British Columbia and Vancouver Coastal Health announced proof that…
Governor Mary Fallin dedicated OMRF’s new 186,000 square foot research tower
On Apr. 21, 2011, Governor Mary Fallin dedicated the Oklahoma Medical Research Foundation’s (OMRF) new 186,000 s.f. research…
UCSF researchers discovered that B cells orchestrate the inflammation of myelin that causes multiple sclerosis
In 2008, University of California, San Francisco (UCSF) researchers discovered that B cells orchestrate the inflammation of myelin…
Research caused concern that hepatitis B vaccination might be linked with multiple sclerosis
In 1998, some research caused concern that hepatitis B vaccination might be linked with multiple sclerosis (MS), a…
Chiron’s Betaseron was approved as the first treatment for multiple sclerosis in 20 years
On Jul. 23, 1993, Chiron and Berlex Laboratories announced that the U.S. Food and Drug Administration (FDA) had…
FDA approved Betaseron, the first of several biotech products that have had a major impact on multiple sclerosis treatment
On Jul. 23, 1993, the U.S. Food and Drug Administration (FDA) approved Betaseron, the first of several biotechnology…